Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Neoleukin Therapeutics In...

    NASDAQ: NLTX · Real-Time Price · USD
    3.49
    0.05 (1.45%)
    At close: Dec 18, 2023, 10:00 PM

    Neoleukin Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -75.14M -57.56M -60.69M
    Depreciation & Amortization
    		 3.25M 2.61M 2.28M
    Stock-Based Compensation
    		 8.32M 8.83M 11.56M
    Other Working Capital
    		 n/a n/a -558K
    Other Non-Cash Items
    		 n/a -376K n/a
    Deferred Income Tax
    		 n/a n/a n/a
    Change in Working Capital
    		 n/a 885K -700K
    Operating Cash Flow
    		 -70.6M -45.61M -47.56M
    Capital Expenditures
    		 -808K -1.11M -3.26M
    Cash Acquisitions
    		 n/a n/a n/a
    Purchase of Investments
    		 -198.45M -107.52M n/a
    Sales Maturities Of Investments
    		 n/a 49.5M n/a
    Other Investing Acitivies
    		 74M n/a n/a
    Investing Cash Flow
    		 -125.26M -59.13M -3.26M
    Debt Repayment
    		 n/a n/a n/a
    Common Stock Repurchased
    		 n/a 82K 372K
    Dividend Paid
    		 n/a n/a n/a
    Other Financial Acitivies
    		 184.12M 161K 732K
    Financial Cash Flow
    		 184.07M 161K 732K
    Net Cash Flow
    		 -11.79M -104.58M -50.09M
    Free Cash Flow
    		 -71.41M -46.72M -50.82M

    Add to Watchlist